FISCHER35.20

Fischer Medical Ventures Limited

· Pharma & Health
AnnualQuarterly₹ CrorePeersTARSONSLAXMIDENTLFABTECHGKBMcap ₹2,304 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY26
31/03/2026
Last 12M
30/06/2026
Revenue from Operations308.6367.1
Other Income12.36.3
Total Income320.9373.4
Expenses
+ Cost of Materials Consumed62.2106.2
+ Purchases of Stock-in-Trade83.598.0
+ Changes in Inventories-3.2-16.0
+ Employee Benefit Expense15.116.5
+ Finance Costs5.88.7
+ Depreciation & Amortisation3.03.6
+ Other Expenses107.8112.3
Total Expenses274.3329.3
EBITDA43.150.1
EBIT40.146.5
Profit
PBT before Exceptional Items46.644.1
Pretax Income46.644.1
+ Current Tax16.614.6
+ Deferred Tax-1.3-0.4
Tax Expense15.314.2
+ Share of Associates & JVs-0.2-0.1
Net Income31.029.8
+ Net Income — Continuing Ops31.229.9
+ Other Comprehensive Income0.10.1
Total Comprehensive Income31.129.9
Per Share
Basic EPS0.482.40
Diluted EPS0.452.55
Other Comprehensive Income — detail
+ Other Comprehensive Income0.10.1
+ Tax on Items NOT to be Reclassified-0.10.0
Per Share — as-filed variants
Basic EPS — Continuing Operations0.482.40
Diluted EPS — Continuing Operations0.452.55
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit166.0178.8
Gross Margin %53.7948.71
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)46.644.1
Net Income Adj (tax-effected)31.029.8
EPS Adj0.482.40
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value1.001.00
Paid Up Equity Capital65.565.5
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.